39 results
8-K
EX-99.1
v7nrnx05 ge2q0
13 Feb 24
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.2
dw0uxk 5x3k
13 Feb 24
Results of Operations and Financial Condition
4:10pm
S-3ASR
EX-4.3
23x4acl
13 Feb 24
Automatic shelf registration
4:04pm
S-3ASR
EX-4.8
gsh7d4w6p
13 Feb 24
Automatic shelf registration
4:04pm
S-3ASR
EX-4.9
ibuj4u0r8yfnww9pj0me
13 Feb 24
Automatic shelf registration
4:04pm
S-3ASR
EX-4.7
7zqo s08ys
13 Feb 24
Automatic shelf registration
4:04pm
8-K
EX-2.1
55zy7wc3wtd
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:05am
S-8
EX-99.4
t98iewd08plrmj
2 Feb 24
Registration of securities for employees
4:04pm
8-K
EX-10.1
0jcrvayf6s84hgd
29 Dec 23
Departure of Directors or Certain Officers
5:00pm
8-K
EX-10.2
zubzk9
29 Dec 23
Departure of Directors or Certain Officers
5:00pm
424B3
sne87 feottarjj
28 Aug 23
Prospectus supplement
9:10am